Differentiation and Application of Human Pluripotent Stem Cells Derived Cardiovascular Cells for Treatment of Heart Diseases: Promises and Challenges
Human pluripotent stem cells (hPSCs) are derived from human embryos (human embryonic stem cells) or reprogrammed from human somatic cells (human induced pluripotent stem cells). They can differentiate into cardiovascular cells, which have great potential as exogenous cell resources for restoring car...
Main Authors: | Yu Gao, Jun Pu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.658088/full |
Similar Items
-
Expansion Culture of Human Pluripotent Stem Cells and Production of Cardiomyocytes
by: Minh Nguyen Tuyet Le, et al.
Published: (2019-05-01) -
Clinical-Grade Human Pluripotent Stem Cells for Cell Therapy: Characterization Strategy
by: Daniela Rehakova, et al.
Published: (2020-03-01) -
Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells
by: Fei Pei, et al.
Published: (2017-03-01) -
Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson’s disease
by: Elena Coccia, et al.
Published: (2021-04-01) -
Schwann Cell Precursors from Human Pluripotent Stem Cells as a Potential Therapeutic Target for Myelin Repair
by: Han-Seop Kim, et al.
Published: (2017-06-01)